BTAIBiotechnology / Biotechnology
BioXcel Therapeutics Inc
30-Day Price
Key Metrics
Latest Close
$1.51
Market Cap
$39M
Shares Outstanding
21,870,000
P/B Ratio
7.84
ROE
-21583.00%
ROA
-15546.00%
Gross Margin
-2819.00%
Operating Margin
-673830.00%
Net Margin
-907061.00%
Debt / Equity
1.21
Current Ratio
1.68
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free